BDBM224283 (r)-3-(6-((1-cyclobutylethyl)amino)- 7-((4,4-dimethylcyclohexyl)methyl)- 8-(4-isopropylpyridin-2-yl)-7h- purin-2-yl)-1,2,4-oxadiazol-5(4h)- one::US9540377, 18.9

SMILES CC(C)c1ccnc(-c2nc3nc(-c4noc(=O)[nH]4)nc(N[C@H](C)C4CCC4)c3n2CC2CCC(C)(C)CC2)c1

InChI Key InChIKey=LPGBJWJNMCZMKQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 224283   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224283BDBM224283(US9540377, 18.9 | (r)-3-(6-((1-cyclobutylethyl)ami...)
Affinity DataIC50: 394nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent